Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check64 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on neoadjuvant sotorasib in patients with KRAS G12C mutated non-small cell lung cancer, while adding a new version revision and a mention of the study's location.SummaryDifference44%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check114 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.